Optimizing Care for Metastatic Non-Small Cell Lung Cancer Without Driver Mutations
home / peer-exchange / optimizing-care-for-metastatic-non-small-cell-lung-cancer-without-driver-mutations
Key opinion leaders discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations.
Episodes
June 27th 2024EP. 1: Biomarker Testing and Guideline-Recommended Care in mNSCLC
Fact checked by:
Mark Socinski, MD, introduces a panel of medical experts as they kick off a discussion surrounding biomarker testing and guideline recommendations in the metastatic non-small cell lung cancer treatment landscape.
